2026-23414NoticeWallet

FDA Says Bromfed-DM Wasn't Pulled for Safety or Effectiveness

Published Date: 11/18/2026

Notice

Summary

The FDA has confirmed that BROMFED-DM syrup, in all its strengths, wasn’t pulled from the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions, as long as they follow the rules. If you rely on this cough and cold syrup, no worries—it’s staying available and safe for now!

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

Generic Approvals May Continue

FDA determined that BROMFED-DM syrup was not withdrawn for reasons of safety or effectiveness. As a result, FDA will not begin procedures to withdraw approval of approved abbreviated new drug applications (ANDAs) that refer to this product, and additional ANDAs referencing this listed drug may be approved if they meet legal and regulatory requirements. The listed drug is ANDA 088811 (initially approved June 07, 1985); the branded holder notified FDA of discontinuation by letter dated January 8, 2026, and a citizen petition was submitted March 26, 2026.

Product Listed as Discontinued (Not for Safety)

FDA will continue to list BROMFED-DM syrup in the Orange Book’s “Discontinued Drug Product List,” which indicates the product was discontinued from marketing for reasons other than safety or effectiveness. The branded holder informed FDA of the discontinuation on January 8, 2026, and FDA found no evidence of withdrawal for safety or effectiveness in its review.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
11/18/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register